These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16084755

  • 1. Oral malignancies following HSCT: graft versus host disease and other risk factors.
    Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A.
    Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
    [Abstract] [Full Text] [Related]

  • 2. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature.
    Demarosi F, Soligo D, Lodi G, Moneghini L, Sardella A, Carrassi A.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jul; 100(1):63-9. PubMed ID: 15953918
    [Abstract] [Full Text] [Related]

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 4. High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.
    Chen MH, Chang PM, Li WY, Hsiao LT, Hong YC, Liu CY, Gau JP, Liu JH, Chen PM, Chiou TJ, Tzeng CH.
    Bone Marrow Transplant; 2011 Apr; 46(4):567-72. PubMed ID: 20622906
    [Abstract] [Full Text] [Related]

  • 5. Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis.
    Shimada K, Yokozawa T, Atsuta Y, Kohno A, Maruyama F, Yano K, Taji H, Kitaori K, Goto S, Iida H, Morishima Y, Kodera Y, Naoe T, Morishita Y.
    Bone Marrow Transplant; 2005 Jul; 36(2):115-21. PubMed ID: 15908969
    [Abstract] [Full Text] [Related]

  • 6. High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.
    Labbé AC, Su SH, Laverdière M, Pépin J, Patiño C, Cohen S, Kiss T, Lachance S, Sauvageau G, Busque L, Roy DC, Roy J.
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1192-200. PubMed ID: 17889356
    [Abstract] [Full Text] [Related]

  • 7. Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Szeto CH, Shek TW, Lie AK, Au WY, Yuen AP, Kwong YL.
    Am J Hematol; 2004 Oct; 77(2):200-2. PubMed ID: 15389910
    [Abstract] [Full Text] [Related]

  • 8. An overview of chronic oral graft-vs-host disease following pediatric hematopoietic stem cell transplantation.
    da Fonseca MA, Hong C.
    Pediatr Dent; 2008 Oct; 30(2):98-104. PubMed ID: 18481573
    [Abstract] [Full Text] [Related]

  • 9. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation.
    Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, Janin A, Soulier J, Gluckman E, Socié G.
    Cancer; 2008 Dec 15; 113(12):3315-22. PubMed ID: 18831513
    [Abstract] [Full Text] [Related]

  • 10. Multiple squamous cell carcinomas of the oral cavity in a young patient with graft-versus-host disease following allogenic bone marrow transplantation.
    Montebugnoli L, Gissi DB, Marchetti C, Foschini MP.
    Int J Oral Maxillofac Surg; 2011 May 15; 40(5):556-8. PubMed ID: 21163622
    [Abstract] [Full Text] [Related]

  • 11. Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study.
    Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socié G.
    J Clin Oncol; 2007 Jun 10; 25(17):2449-54. PubMed ID: 17557958
    [Abstract] [Full Text] [Related]

  • 12. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
    Gallagher G, Forrest DL.
    Cancer; 2007 Jan 01; 109(1):84-92. PubMed ID: 17131350
    [Abstract] [Full Text] [Related]

  • 13. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H, Huang XJ, Liu KY, Xu LP, Wang H, Liu DH, Lu J, Lu DP.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3062-6. PubMed ID: 16324408
    [Abstract] [Full Text] [Related]

  • 14. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
    Luo XD, Liu QF, Ning J, Wei YQ, Fan ZP, Zhang Y, Sun J.
    Zhonghua Yi Xue Za Zhi; 2007 Dec 11; 87(46):3280-3. PubMed ID: 18396625
    [Abstract] [Full Text] [Related]

  • 15. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA.
    Bone Marrow Transplant; 2007 May 11; 39(9):555-61. PubMed ID: 17351645
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary Nocardia and Aspergillus co-infection in a patient with chronic graft-versus-host disease.
    Hamadani M, Benson DM, Blum W, Garzon R, Devine SM.
    Transpl Infect Dis; 2008 Feb 11; 10(1):24-6. PubMed ID: 17651365
    [Abstract] [Full Text] [Related]

  • 17. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.
    Transpl Immunol; 2006 Jan 11; 15(3):223-7. PubMed ID: 16431290
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M, Porcher R, De Castro Araujo R, de Latour RP, Devergie A, Rocha V, Larghero J, Adès L, Ribaud P, Mary JY, Socié G.
    Biol Blood Marrow Transplant; 2007 Nov 11; 13(11):1304-12. PubMed ID: 17950917
    [Abstract] [Full Text] [Related]

  • 19. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease.
    Xu LP, Zhang HY, Huang XJ, Liu KY, Liu DH, Han W, Chen H, Chen YH, Gao ZY, Zhang YC, Lu DP.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1666-71. PubMed ID: 17935666
    [Abstract] [Full Text] [Related]

  • 20. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M.
    Am J Hematol; 2006 Jul 05; 81(7):525-31. PubMed ID: 16755559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.